Related references
Note: Only part of the references are listed.Copper chelation by tetrathiomolybdate inhibits vascular inflammation and atherosclerotic lesion development in apolipoprotein E-deficient mice
Hao Wei et al.
ATHEROSCLEROSIS (2012)
Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
G. J.S. Cooper
CURRENT MEDICINAL CHEMISTRY (2012)
Cellular Responses to the Metal-Binding Properties of Metformin
Lisa Logie et al.
DIABETES (2012)
Chelation: A Fundamental Mechanism of Action of AGE Inhibitors, AGE Breakers, and Other Inhibitors of Diabetes Complications
Ryoji Nagai et al.
DIABETES (2012)
Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
Vasundhara Kain et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Therapeutic Potential of Copper Chelation with Triethylenetetramine in Managing Diabetes Mellitus and Alzheimer's Disease
Garth J. S. Cooper
DRUGS (2011)
Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments
J. Lu et al.
DIABETOLOGIA (2010)
Pharmacokinetics, Pharmacodynamics, and Metabolism of Triethylenetetramine in Healthy Human Participants: An Open-Label Trial
Jun Lu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Illuminating the molecular basis of diabetic arteriopathy: A proteomic comparison of aortic tissue from diabetic and healthy rats
Mia Juellig et al.
PROTEOMICS (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study
G. J. S. Cooper et al.
DIABETOLOGIA (2009)
Pharmacokinetic and Pharmacodynamic Modeling of a Copper-Selective Chelator (TETA) in Healthy Adults
Hea-Young Cho et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Multiecho Dixon Fat and Water Separation Method for Detecting Fibrofatty Infiltration in the Myocardium
Peter Kellman et al.
MAGNETIC RESONANCE IN MEDICINE (2009)
Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats
Deming Gong et al.
PROTEOMICS (2009)
Altered calcium homeostasis does not explain the contractile deficit of diabetic cardiomyopathy
Lin Zhang et al.
DIABETES (2008)
A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-β activation in the kidneys of rats used as a model of diabetes
D. Gong et al.
DIABETOLOGIA (2008)
Is the failing heart out of fuel or a worn engine running rich?: A study of mitochondria in old spontaneously hypertensive rats
Mia Juellig et al.
PROTEOMICS (2008)
Development and validation of a rapid HPLC method for the simultaneous determination of triethylenetetramine and its two main metabolites in human serum
Asma Othman et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Determination of triethylenetetramine (TETA) and its metabolites in human plasma and urine by liquid chromatography-mass spectrometry (LC-MS)
Jun Lu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Diabetic cardiomyopathy revisited
Sihem Boudina et al.
CIRCULATION (2007)
Reversal of diabetes-evoked changes in mitochondrial protein expression of cardiac left ventricle by treatment with a copper(II)-selective chelator
Mia Jullig et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats
Deming Gong et al.
MOLECULAR PHARMACOLOGY (2006)
The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model
George J. Brewer et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
The role of AGEs and AGE inhibitors in diabetic cardiovascular disease
MC Thomas et al.
CURRENT DRUG TARGETS (2005)
Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation - Quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals
GJS Cooper et al.
DIABETES (2005)
Regeneration of the heart in diabetes by selective copper chelation
GJS Cooper et al.
DIABETES (2004)
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats
AIM Al-Shafei et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Mechanism by which metformin reduces glucose production in type 2 diabetes
RS Hundal et al.
DIABETES (2000)
Glycochelates and the etiology of diabetic peripheral neuropathy
MW Qian et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Share Paper
